3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Huntington Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, WJ; Yao, WJ | 1 |
| Decristoforo, C; Diederen, E; Donnemiller, E; Oberladstätter, M; Poewe, W; Scherfler, C; Scholz, SW; Stefanova, N; Virgolini, I; Wenning, GK | 1 |
| Bartenstein, P; Lerch, H; Masur, H; Oberwittler, C; Saur, HB; Schober, O | 1 |
| Ballinger, JR; Fornazzari, L; Ichise, M; Kirsh, JC; Toyama, H | 2 |
| Abrams, DN; Greenberg, CR; Hobson, D; Leslie, WD | 1 |
| Hondl, N; Ladurner, G; Staffen, W; Trinka, E; Zenzmaier, R | 1 |
| Benoit, J; Besnard, J; Bodard, S; Chalon, S; Gouhier, C; Guilloteau, D; Venier-Julienne, MC | 1 |
| Angelberger, P; Brücke, T; Deecke, L; Küfferle, B; Müller, C; Podreka, I; Topitz, A; Wenger, S | 1 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Huntington Disease
| Article | Year |
|---|---|
[Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].
Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Benzamides; Brain; Cerebellum; Cerebrovascular Circulation; Dopamine Antagonists; Frontal Lobe; Humans; Huntington Disease; Iodine Radioisotopes; Middle Aged; Organotechnetium Compounds; Oximes; Parkinson Disease; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1994 |
8 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Huntington Disease
| Article | Year |
|---|---|
SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.
Topics: Adult; Benzamides; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Female; Humans; Huntington Disease; Male; Middle Aged; Neural Pathways; Organotechnetium Compounds; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Reproducibility of Results; Sensitivity and Specificity; Substantia Nigra; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tropanes | 2013 |
Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
Topics: Animals; Benzamides; Brain Chemistry; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Gamma Cameras; Huntington Disease; Image Interpretation, Computer-Assisted; Immunohistochemistry; Linear Models; Male; Motor Activity; Neostriatum; Nerve Tissue Proteins; Neurons; Phosphoproteins; Pyrrolidines; Quinolinic Acid; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2005 |
Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
Topics: Adolescent; Adult; Aged; Benzamides; Brain; Cerebrovascular Circulation; Female; Humans; Huntington Disease; Male; Middle Aged; Organotechnetium Compounds; Oximes; Pyrrolidines; Receptors, Dopamine D2; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |
Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans.
Topics: Adult; Aged; Alcoholism; Benzamides; Female; Hallucinations; Humans; Huntington Disease; Male; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1993 |
Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging.
Topics: Adult; Benzamides; Brain; Brain Chemistry; Contrast Media; Dopamine Antagonists; Humans; Huntington Disease; Iodine Radioisotopes; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Risk Factors; Tomography, Emission-Computed, Single-Photon | 1996 |
SPET investigations in extrapyramidal diseases using specific ligands.
Topics: Adult; Aged; Benzamides; Brain; Cocaine; Dopamine Antagonists; Hepatolenticular Degeneration; Humans; Huntington Disease; Iodine Radioisotopes; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Reference Values; Supranuclear Palsy, Progressive; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1997 |
Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide.
Topics: Animals; Antineoplastic Agents; Autoradiography; Benzamides; Biocompatible Materials; Corpus Striatum; Denervation; Dopamine Antagonists; Drug Carriers; Huntington Disease; Interneurons; Iodine Radioisotopes; Isoquinolines; Lactic Acid; Male; Microspheres; Nerve Growth Factor; Neuroprotective Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrrolidines; Quinolinic Acid; Rats; Rats, Wistar; Receptors, Dopamine D2; Tritium | 2000 |
Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
Topics: Adult; Aged; Aging; Antipsychotic Agents; Benzamides; Brain Diseases; Cerebellum; Corpus Striatum; Frontal Lobe; Humans; Huntington Disease; Iodine Radioisotopes; Levodopa; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1991 |